期刊文献+

淋巴细胞亚群预测脓毒性休克患者预后的价值 被引量:1

Prognostic value of lymphocyte subsets in patients with septic shock
下载PDF
导出
摘要 目的:观察脓毒性休克患者外周血淋巴细胞亚群变化与预后的关系,探讨外周血淋巴细胞亚群预测脓毒性休克预后的临床价值。方法:回顾性分析2018年8月1日~2020年7月31日在弋矶山医院重症医学科收治的脓毒性休克患者50例。根据确诊脓毒性休克后30 d内患者的预后情况将患者分为两组:死亡组(n=21)和生存组(n=29)。记录脓毒性休克患者确诊当日的年龄、性别、心率、体温、白细胞计数等临床资料及外周血淋巴细胞亚群。根据当天淋巴细胞总数计算CD4+、CD8+、CD16+56+、CD19+的淋巴细胞数。结果:两组患者性别、年龄、体温、降钙素原(PCT)、C反应蛋白、白细胞、ICU住院时间差异均无统计学意义(P>0.05)。死亡组患者CD4+T淋巴细胞数以及CD4+T/CD8+T淋巴细胞比值低于存活组,差异有统计学意义(P<0.05)。CD8+T淋巴细胞数、CD16+56+、CD19+淋巴细胞数两组间差异无统计学意义(P>0.05)。死亡组患者心率、急性生理与慢性健康状况评分系统Ⅱ(APACHEⅡ)评分高于存活组,差异有统计学意义(P<0.05)。结论:脓毒性休克患者血CD4+T淋巴细胞数、CD4+T/CD8+T淋巴细胞比值对早期判断患者预后有指导意义。 Objective:To assess the clinical value of changes of peripheral blood lymphocyte subsets in predicting the prognosis in patients with septic shock.Methods:Retrospective analysis was performed in 50 cases of septic shock treated in the ICU of our hospital between August 1,2018 and July 31,2020.All cases were divided into detath group(n=21)and survival group(n=29)according to the prognosis within 30 days after diagnosis.The baseline data,including patient′s age,gender,heart rate,body temperature,leukocyte count and levels of peripheral blood lymphocyte subsets at the day of diagnosis,were maintained.The number of CD4+,CD8+,CD16+56+and CD19+lymphocyte was calculated according to the total count of lymphocytes measured at the day of diagnosis.Results:There were no significant differences in gender,age,body temperature,procalcitonin(PCT),C-reactive protein,white blood cell count and length of stay in ICU between the two groups(P>0.05).The cell count of CD4+T lymphocyte and the ratio of CD4+T/CD8+T lymphocyte cells in the death group were significantly lower than those in the survival group(P<0.05),yet the ratio of CD8+T,CD16+56+and CD19+lymphocytes showed no significant difference between groups(P>0.05).Patients in the death group had significantly higher heart rate and APACHEⅡscore than those in the survival group(P<0.05).Conclusion:CD4+T lymphocytes and CD4+T/CD8+T lymphocyte cell ratio in peripheral blood can be valuable in early predicting the prognosis of patients with septic shock.
作者 王忠涵 鲁卫华 夏炎 姜晶晶 WANG Zhonghan;LU Weihua;XIA Yan;JIANG Jingjing(Department of Critical Care Medicine,The First Affiliated Hospital of Wannan Medical College,Wuhu 241001,China)
出处 《皖南医学院学报》 CAS 2021年第6期543-545,549,共4页 Journal of Wannan Medical College
基金 安徽省中央引导地方科技发展专项项目(201907d07050001) 弋矶山医院“高峰”培育计划(GF2019J03) 安徽省学术和技术带头人后备人选科研活动经费资助项目(2017H145)。
关键词 脓毒性休克 淋巴细胞亚群 急性生理与慢性健康状况评分系统Ⅱ septic shock lymphocyte subsets APACHEⅡ
  • 相关文献

参考文献7

二级参考文献43

  • 1曾钧.单核细胞趋化蛋白-1与炎性疾病的研究现状[J].南方医科大学学报,2001,25(S1):84-87. 被引量:10
  • 2Gibot S,Bene MC,Noel R,et al.Combination biomarkers to diagnose sepsis in the critically ill patient[J].American journal of respiratory and critical care medicine,2012,186(1):65-71.
  • 3Antonelli M, Azoulay E, Bonten M, et al. Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control ~J]. Intensive Care Med, 2010, 36 (2) : 196- 209.
  • 4Rodrfguez F, Barrera L, De La Rosa G, et al. The epidemiology of sepsis in Colombia: A prospective muhicenter cohort study in ten university hospitals [J~. Crit Care Med, 2011, 39 (7) : 1675- 1682.
  • 5Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland [ J ]. Crit Care Med, 2003, 31 (9) : 2332-2338.
  • 6Alberti C, Bmn-Bnisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an internationalmuhicentre cohort study [ J ]. Intensive Care Med, 2002, 28 (2) : 108-121.
  • 7Levy MM, Artigas A, Phillips GS, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study [J]. Lancet Infect Dis, 2012, 12 (12) : 919-924.
  • 8Hotchkiss RS, bionneret G, Payen D. Immunosuppression in sepsis : a novel understanding of the disorder and a new therapeutic approach [J]. Lancet Infect Dis, 2013, 13 (3) : 260-268.
  • 9Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign : international guidelines for management of severe sepsis and septic shock, 2012 [J]. Intensive Care Med, 2013, 39 (2) : 165-228.
  • 10Andaluz-Ojeda D, Bobillo F, Iglesias V, et al. A combined score of pro-and anti-inflammatory interleukins improves mortality prediction in severe sepsis [ J]. Cytokine, 2012, 57 (3) : 332- 336.

共引文献137

同被引文献15

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部